DEVA:IST
Deva Holding AS
77,10 TRY
arrow_upward
+1,98%(+1,50) 1D
20. okt., 18.10.00 GMT+3 · TRY
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for DEVA...
Åbn
75,60 TRY
Høj
77,20 TRY
Lav
74,50 TRY
Markedsværdi
15,42 mia.
Gns. vol.
590,01 t
Volumen
0,00
Højeste i 52 uger
109,30 TRY
Laveste i 52 uger
57,50 TRY
Indtægt pr. aktie
-4,21 TRY
Aktier i omløb
200,02 mio.
Antal ansatte
3 t
Åbn
75,60 TRY
Høj
77,20 TRY
Lav
74,50 TRY
Markedsværdi
15,42 mia.
Gns. vol.
590,01 t
Volumen
0,00
Højeste i 52 uger
109,30 TRY
Laveste i 52 uger
57,50 TRY
Indtægt pr. aktie
-4,21 TRY
Aktier i omløb
200,02 mio.
Antal ansatte
3 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Traders Union
·
for 12 timer siden
Grant Cardone: 41 AI-relaterede virksomheder udgør 49 % af S&P 500-markedet
Yahoo Finance
·
for 31 minutter siden
FF EAI Robotics Ecosystem Inc. Announces Details for Its Listing Ceremony and Nasdaq Investor Day, Taking Place on Monday, Oct. 26, at Nasdaq's MarketSite in NYC
Simply Wall Street
·
for 15 minutter siden
Top 3 Penny Stocks To Watch In October 2026
Moomoo
·
for 51 minutter siden
NYSE Is Getting Trounced in the Battle for Wall Street's Biggest IPOs -- WSJ
Profil
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements.
A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas.
As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
Om Deva Holding AS